Inventor
VENABLE JENNIFER D
US42 patents
⚠️ This page may combine multiple inventors who share the name “VENABLE JENNIFER D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
36 patentsUS7507737B2Mar 24, 2009
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4receptor
JANSSEN PHARMACEUTICA NV37 citations96
US8598189B2Dec 3, 2013
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV12 citations92
US7928131B2Apr 19, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV14 citations92
US7253200B2Aug 7, 2007
Imidazole compounds
JANSSEN PHARMACEUTICA NV24 citations92
US8343989B2Jan 1, 2013
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV10 citations84
US10981911B2Apr 20, 2021
Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV6 citations83
US10717745B2Jul 21, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV5 citations82
US7705149B2Apr 27, 2010
Benzoimidazole compounds
JANSSEN PHARMACEUTICA NV4 citations73
US7432378B2Oct 7, 2008
Benzoimidazole compounds
JANSSEN PHARMACEUTICA NV8 citations73
US12065446B2Aug 20, 2024
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV1 citations72
US11827638B2Nov 28, 2023
Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
JANSSEN PHARMACEUTICA NV2 citations72
US11319329B2May 3, 2022
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV1 citations72
US10947252B2Mar 16, 2021
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV3 citations71
US10934310B2Mar 2, 2021
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV4 citations71
US8962644B2Feb 24, 2015
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV2 citations62
US7723526B2May 25, 2010
Benzoimidazole compounds
JANSSEN PHARMACEUTICA NV1 citations62
US7723359B2May 25, 2010
Benzoimidazole compounds
JANSSEN PHARMACEUTICA NV1 citations62
US7662966B2Feb 16, 2010
Benzoimidazole compounds
JANSSEN PHARMACEUTICA NV1 citations62
US11897900B2Feb 13, 2024
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US11427601B1Aug 30, 2022
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US12215111B2Feb 4, 2025
Imidazopyridazine IL-17 inhibitor compounds
JANSSEN PHARMACEUTICA NV0 citations56
US9365548B2Jun 14, 2016
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations52
US8039498B2Oct 18, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV0 citations52
US8017600B2Sep 13, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV0 citations52
US8017639B2Sep 13, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV0 citations52
US7956057B2Jun 7, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV0 citations52
US7956066B2Jun 7, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV0 citations52
US7956071B2Jun 7, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV0 citations52
US7951808B2May 31, 2011
Imidazole compounds
JANSSEN PHARMACEUTICA NV0 citations52
US8716475B2May 6, 2014
2-aminopyrimidine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations51
US10822348B2Nov 3, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10800792B2Oct 13, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10689396B2Jun 23, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US7589087B2Sep 15, 2009
Benzoimidazol-2-yl pyridines as modulators of the histamine H4receptor
JANSSEN PHARMACEUTICA NV0 citations42
US10172856B2Jan 8, 2019
2,4-diaminopyrimidine derivatives as histamine H4 modulators
JANSSEN PHARMACEUTICA NV0 citations41
US7504426B2Mar 17, 2009
Heterocyclic compounds
JANSSEN PHARMACEUTICA NV0 citations41
EDWARDS JAMES P
5 patentsUS8193178B2Jun 5, 2012
Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
EDWARDS JAMES P6 citations81
US8937075B2Jan 20, 2015
Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
EDWARDS JAMES P0 citations49
US8927555B2Jan 6, 2015
Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
EDWARDS JAMES P0 citations49
US8445482B2May 21, 2013
Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
EDWARDS JAMES P0 citations49
US8440654B2May 14, 2013
Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
EDWARDS JAMES P0 citations49